Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.53B |
| 2 |
American Express
AXP
|
+$368M |
| 3 |
Capital One
COF
|
+$138M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$98.1M |
| 5 |
Apollo Global Management
APO
|
+$96.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.04B |
| 2 |
Microsoft
MSFT
|
+$804M |
| 3 |
Amazon
AMZN
|
+$353M |
| 4 |
NVIDIA
NVDA
|
+$280M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.2% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.24% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Rhythm Pharmaceuticals
RYTM
$7.99B
| $1.63M | ﹤0.01% |
98,800
+1,500
| +2% | +$27.1K |
|
2027
MarineMax
HZO
$1.15B
| $1.63M | ﹤0.01% |
47,600
+700
| +1% | +$20.6K |
|
|
HUT
2028
Hut 8
HUT
$10.2B
| $1.62M | ﹤0.01% |
+97,560
| New | +$1M |
|
2029
Collegium Pharmaceutical
COLL
$913M
| $1.62M | ﹤0.01% |
75,300
+6,400
| +9% | +$145K |
|
|
NNDM
2030
Nano Dimension
NNDM
$348M
| $1.62M | ﹤0.01% |
559,700
| – | – |
|
2031
Regenxbio
RGNX
$704M
| $1.61M | ﹤0.01% |
80,500
+1,100
| +1% | +$21.2K |
|
2032
ADMA Biologics
ADMA
$2.11B
| $1.61M | ﹤0.01% |
435,500
+12,500
| +3% | +$46.3K |
|
|
CHUY
2033
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.6M | ﹤0.01% |
39,200
+400
| +1% | +$14.9K |
|
2034
IMAX
IMAX
$2.92B
| $1.6M | ﹤0.01% |
94,000
-2,600
| -3% | -$49.3K |
|
2035
CRA International
CRAI
$1.07B
| $1.59M | ﹤0.01% |
15,600
+200
| +1% | +$20.1K |
|
2036
Usana Health Sciences
USNA
$252M
| $1.59M | ﹤0.01% |
25,200
+300
| +1% | +$19.1K |
|
2037
Standard Motor Products
SMP
$870M
| $1.59M | ﹤0.01% |
42,300
+400
| +1% | +$14.6K |
|
|
SHYF
2038
DELISTED
The Shyft Group
SHYF
| $1.59M | ﹤0.01% |
71,900
| – | – |
|
2039
Sonic Automotive
SAH
$2.51B
| $1.58M | ﹤0.01% |
33,200
-6,500
| -16% | -$300K |
|
2040
Trupanion
TRUP
$1.36B
| $1.58M | ﹤0.01% |
80,410
+5,400
| +7% | +$152K |
|
2041
JetBlue
JBLU
$2.19B
| $1.58M | ﹤0.01% |
178,500
+3,700
| +2% | +$26.9K |
|
|
DCBO
2042
Docebo
DCBO
$594M
| $1.58M | ﹤0.01% |
39,900
+500
| +1% | +$18.1K |
|
|
RWT
2043
Redwood Trust
RWT
$599M
| $1.58M | ﹤0.01% |
247,600
+2,900
| +1% | +$18.1K |
|
|
FBMS
2044
DELISTED
The First Bancshares, Inc.
FBMS
| $1.57M | ﹤0.01% |
60,930
+11,600
| +24% | +$297K |
|
|
SII
2045
Sprott
SII
$3.03B
| $1.57M | ﹤0.01% |
48,575
+600
| +1% | +$20.7K |
|
|
PGRE
2046
DELISTED
Paramount Group
PGRE
| $1.57M | ﹤0.01% |
354,643
-24,900
| -7% | -$111K |
|
2047
SkinHealth Systems
SKIN
$85.9M
| $1.57M | ﹤0.01% |
187,500
+2,100
| +1% | +$21.8K |
|
2048
TORM
TRMD
$3.01B
| $1.56M | ﹤0.01% |
64,971
+2,264
| +4% | +$63K |
|
|
TWKS
2049
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $1.56M | ﹤0.01% |
+207,000
| New | +$1.53M |
|
2050
PubMatic
PUBM
$787M
| $1.56M | ﹤0.01% |
85,400
-3,100
| -4% | -$49.3K |
|
Similar funds
Swiss National Bank's Q2 2023 Portfolio in Review
As of Q2 2023, Swiss National Bank held 2,706 positions worth $147B, up 0.92% from $146B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $9.97B in Q2 2023, closing 106 positions and reducing 972 holdings. Its most notable exit was Shaw Communications Inc., an estimated $57.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Berkshire Hathaway Class B worth $1.6B.
- Swiss National Bank's largest Q2 2023 buy was Berkshire Hathaway Class B: 4,684,505 shares worth $1.6B.
- Swiss National Bank added most to Uber in Q2 2023, an estimated $22.7M increase.
- Swiss National Bank's biggest Q2 2023 reduction was Apple, cutting an estimated $1.04B.
- Swiss National Bank fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $57.3M.
- Swiss National Bank's ten largest holdings make up 28% of its $147B portfolio in Q2 2023.
- Swiss National Bank opened 63 new positions and closed 106 in Q2 2023.
- Swiss National Bank's portfolio value rose 0.92% quarter-over-quarter to $147B.
Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.